As of 2025-07-09, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (16.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -2478.6%.
The range of the Relative Valuation is (12.76) - (23.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 18.4x | 12.9x |
| Forward P/E multiples | 10.1x - 20.9x | 13.4x |
| Fair Price | (12.76) - (23.26) | (16.64) |
| Upside | -1923.3% - -3424.6% | -2478.6% |
| Date | P/E |